What is MMIRF stock price today?

MMIRF (MedMira Inc) stock is trading at $0.01 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MMIRF stock going up or down today?

MMIRF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MMIRF stock now?

The decision to buy MMIRF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MMIRF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MMIRF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MMIRF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MMIRF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MMIRF's P/E ratio?

P/E ratio data for MMIRF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MMIRF's market cap?

MMIRF (MedMira Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is MMIRF's price to book ratio?

Price-to-book ratio for MMIRF is available on our dashboard along with other valuation metrics.

Does MMIRF pay dividends?

MMIRF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MMIRF's dividend yield?

MMIRF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MMIRF stock a good long-term investment?

MMIRF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MMIRF's revenue growth rate?

MMIRF has shown revenue growth of -0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for MMIRF are available on our dashboard with complete income statement analysis.

What are the risks of investing in MMIRF?

Key risks for MMIRF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MMIRF compare to its competitors?

Compare MMIRF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MMIRF's performance and positioning.

What is MMIRF's stock price target for 2026?

Our AI model provides price targets for MMIRF based on fundamental analysis: Bull case $0.02 (+30%), Base case $0.01 (+15%), Bear case $0.01 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MMIRF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MMIRF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MMIRF's next earnings report?

MMIRF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MMIRF - MedMira Inc

NYSE * Healthcare * Biotechnology

$0.01

+$0.00 (+0.00%)

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

MMIRF Key Statistics

Market Cap

$9.64M

000

Revenue Growth

-0.1%

How MMIRF Compares to Peers

MMIRF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MMIRF(This stock)	$9.64M	N/A	-0%	0.0%	-
AMGNAmgen Inc	$177.92B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.99B	19.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.16B	31.1	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.69B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.12B	15.0	0%	0.2%	vs BIIB

MedMira Inc Company Information

Headquarters: 155 Chain Lake Drive, Halifax, NS, Canada, B3S 1B3, undefined
Website: medmira.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: January 20, 2026 at 8:55 PM EST

Ready to invest in MMIRF?

Commission-free trading available. Affiliate links.

Upcoming Events for MMIRF

Dashboard

Enter a ticker to analyze